Natural Products In Drug Discovery - eNewsletter
Verticaltalk Pharma e-Newsletter
Volume 2 No.7 2007
Natural Products
In Drug Discovery
Pharma Focus Asia - Natural Products In Drug Discovery
Pharma Focus Asia - Media Pack
  Pharma Focus Asia News Roundup News Roundup
Bristol-Myers Squibb and Gilead Sciences to commericalise ATRIPLA(R) in Europe Oxford Genome Sciences and Amgen collaborate for novel therapeutic Antibodies
Bristol-Myers Squibb and Gilead Sciences to commericalise ATRIPLA(R) in Europe ZymoGenetics and Merck Serono initiate phase 2/3 Clinical Trial of Atacicept
Bristol-Myers Squibb and Gilead Sciences to commericalise ATRIPLA(R) in Europe Bristol-Myers Squibb and Gilead Sciences to commericalise ATRIPLA(R) in Europe
GlaxoSmithKline and OncoMed enter into agreement for stem cell therapeutics GlaxoSmithKline and OncoMed enter into agreement for stem cell therapeutics
Celldex Therapeutics receives Orphan Drug Designation for CDX-11 Celldex Therapeutics receives Orphan Drug Designation for CDX-110
  Pharma Focus Asia Events Pharma Events
Pharma Future Expo' 07, Singapore Pharma Future Expo' 07, Singapore, Dec 14 2007 - Dec 16 2007
Pharmaceutical EXPO 2007, Varanasi, India Pharmaceutical EXPO 2007, Varanasi, India, Dec 21 2007
1st Pharm Tech IAPST International Conference, Kolkata, India 1st Pharm Tech IAPST International Conference, Kolkata, India, Jan 19 2008 - Jan 20 2008
Roles of Eukaryotic Cell Surface Macromolecules Roles of Eukaryotic Cell Surface Macromolecules, Jan 21 2008- Jan 25 2008
 
  Pharma Focus Asia Press Releases Pharma Press Releases
Fourth Genmab Antibody Developed Under Roche Collaboration to Enter Clinic Fourth Genmab Antibody Developed Under Roche Collaboration to Enter Clinic
Protagen and Tomy Digital Biology announce distribution agreement for Modiro™ in Japan Protagen and Tomy Digital Biology announce distribution agreement for Modiro™ in Japan
Acquisition of Adams Respiratory Therapeutics by Reckitt Benckiser Acquisition of Adams Respiratory Therapeutics by Reckitt Benckiser
Access Pharmaceuticals Demonstrates Ability to Significantly Reduce Glucose Levels in Pre-clinical Testing of Cobalamin(TM) Oral Insulin Access Pharmaceuticals Demonstrates Ability to Significantly Reduce Glucose Levels in Pre-clinical Testing of Cobalamin(TM) Oral Insulin
Ankylosing Spondylitis Drug Market Will Reach $661 Million in 2016 Ankylosing Spondylitis Drug Market Will Reach $661 Million in 2016
Current Issue   |   Archives   |   Advertise
In this issue of The Pharma Edge
FOREWORD
Drug Discovery
Back to Mother Nature

Aala Santhosh Reddy, Editor, Pharma Focus Asia
COVER STORY
Natural Products in Drug Discovery

K K Bhutani, Professor and Head, Department of Natural Products and
Dean, NIPER, India		 K K Bhutani, Professor and Head, Department of Natural Products and Dean
STRATEGY
Challenges for Pharmaceutical Sales Forces
Lessons from other sectors

Reinhard Angelmar, The Salmon and Rameau Fellow Healthcare Management and
Professor of Marketing INSEAD, France
Liver Caner Treatment in Asia
From little acorns

David Twinberrow, Senior Director Oncology, EMEA & Asia Pacific, IMS Health, United Kingdom
Generic to Innovative
Transition of Indian pharmaceutical companies

Dilip Shah, CEO, Vision Consulting Group, India
International Strategic Alliances
Positioning the Asian biotechnology company
Stephen M Sammut, Senior Fellow, Wharton Health Care Systems and Entrepreneurship, USA
RESEARCH & DEVELOPMENT
Getting to the Heart of a Tumor Cell
Targeting the nucleus

David Andrew Jans, Professor and Head, Nuclear Signaling Laboratory, Department of Biochemistry and Molecular Biology, Monash University, Australia

Kylie M Wagstaff, Post-doctoral Researcher, Nuclear Signaling Laboratory, Department of Biochemistry and Molecular Biology, Monash University, Australia
The Next Generation of Recombinant Immunotoxins
Reducing immunogenicity of the cytotoxic part

Stefan Barth, Head, Department of Pharmaceutical Product Development Fraunhofer IME, Germany
Assessing the Immunogenicity of Protein Therapeutics

Philippe Stas, Chief Operating Officer, AlgoNomics NV, Belgium
Automated Purification of Natural and Synthetic Compounds
Synergy between the industry and academia

Athos C Rosselli, Sales & Marketing Manager, Pacific Rim, Scientific Instruments, Teledyne Isco, Inc., USA

Jack E Silver, Product Manager, Chromatography, Scientific Instruments, Teledyne Isco, Inc., USA
Biomedical Polymers
SDrug delivery and molecular imaging

Zheng-Rong Lu, Assistant Professor, Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, USA

Furong Ye, Graduate Student, Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, USA
CLINICAL TRIALS
Clinical Outsourcing in Japan
Ready to fulfill its destiny?

Christopher R Albani, Partner, PRTM, Japan

Yorozu Tabata, Principal, PRTM, Japan
Clinical Trial Integration
Adopting an innovative approach

Solomon Shacter, Director, Product Management - Platform Solutions, ClinPhone Plc, USA
Site Management Organisations in Asian Clinical Trials
Providing competitive advantage

Sergei Drapkin, Managing Director, ERGOMED Clinical Research, Russia
Clinical and Non-clinical Investigations
Improve the quality of development candidates

Colin W Vose, Senior Director, Strategic Drug Development Group, Quintiles Limited, United Kingdom
MANUFACTURING
Manufacturing Control Systems
The next big thing for the life sciences industry

Mark Albano, Life Sciences Marketing Manager, Honeywell Process Solutions, USA

Rajeev Joshi, Manager, Development Engineering, Honeywell, USA
Advanced Emulsification Technologies
Narrow drop size distributions in the nanometer region

Ludger Fischer, Managing Director, AC Serendip Limited, Germany
Developing a Process Excellence Culture
Bruce Sawyer, Senior Director, Operations Excellence GPSG, Johnson & Johnson, USA
Pharmaceutical Manufacturers
Embracing Lean Six Sigma

John E Danese, Product Strategy Director, LifeSciences, Oracle, USA

Dennis Constantinou, Senior Director, LifeSciences, Oracle, USA
INFORMATION TECHNOLOGY
Life Sciences Manufacturing
Promise of service oriented architecture

Daniel Matlis, President, Axendia, USA
   
Send this newsletter to a friend or colleague.
Your Name: Friend's Name: Email:
You are receiving this email because you are either a registered member or requested for a newsletter from Verticaltalk Pharma.
To SUBSCRIBE
QUESTIONS: For questions or assistance, please contact our Customer Support Staff : verticaltalkpharma@ochre-media.com
PRIVACY: View our Privacy Policy
Copyright © 2008 Ochre Media Private Limited. All rights reserved.
Pharma Focus Asia - Natural Products in Drug Discovery IMS